SEC Form 4 · accession 0001179110-15-001625

ST JUDE MEDICAL, LLC · STJ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President, Americas

Period of report

Jan 30, 2015

Accepted (ET)

Feb 3, 2015 · 6:19 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000203077

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 30, 2015	M	16,666	$34.96	A	26,433	D
Common Stock^F1	Jan 30, 2015	S	16,666	$65.86	D	9,767	D
Common Stock	Jan 30, 2015	M	21,250	$35.27	A	31,017	D
Common Stock^F1	Jan 30, 2015	S	21,250	$65.86	D	9,767	D
Common Stock^F2	Jan 30, 2015	S	8,795	$65.89	D	972	D
Common Stock	Jan 30, 2015	S	972	$65.70	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F3	$34.96	Jan 30, 2015	M	16,666	D	Dec 17, 2012	Dec 12, 2019	Common Stock	33,332	16,666	D
Stock Options (Right to Buy)^F3	$35.27	Jan 30, 2015	M	21,250	D	Dec 17, 2013	Dec 10, 2020	Common Stock	63,750	42,500	D

F1The price in Column 4 is a weighted average. The prices actually received ranged from $65.48 to $66.20. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2The price in Column 4 is a weighted average. The prices actually received ranged from $65.51 to $66.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The option shares will vest 25% on December 17th annually beginning the date shown.